We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of ACOR yet.

ACOR Hedge Fund Activity: Q3 2024 in Review

0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2024, worth a combined $0 — down 100% from $8K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ACOR and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Acadian Asset Management, exiting entirely with an estimated $8K sold.

  • 0 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2024, down from 2 in Q2 2024.
  • Funds reported $0 of Acorda Therapeutics stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Acorda Therapeutics positions in Q3 2024 and 2 closed out, a net change of -2 holders.
  • The largest Acorda Therapeutics seller in Q3 2024 was Acadian Asset Management, an estimated $8K sold.

Based on aggregated 13F filings for Q3 2024.